Nexpovio Liên Minh Châu Âu - Tiếng Iceland - EMA (European Medicines Agency)

nexpovio

stemline therapeutics b.v. - selinexor - mergæxli - Æxlishemjandi lyf - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Zynlonta Liên Minh Châu Âu - Tiếng Iceland - EMA (European Medicines Agency)

zynlonta

swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - Æxlishemjandi lyf - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.

VORTEMYEL Stungulyfsstofn, lausn 3,5 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

vortemyel stungulyfsstofn, lausn 3,5 mg

zentiva k.s.* - bortezomibum inn - stungulyfsstofn, lausn - 3,5 mg

Bortezomib W&H Stungulyfsstofn, lausn 3,5 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

bortezomib w&h stungulyfsstofn, lausn 3,5 mg

williams & halls ehf.* - bortezomibum inn - stungulyfsstofn, lausn - 3,5 mg

Dexametason Abcur Tafla 1 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

dexametason abcur tafla 1 mg

abcur ab - dexamethasonum fosfat - tafla - 1 mg

Dexametason Abcur Tafla 4 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

dexametason abcur tafla 4 mg

abcur ab - dexamethasonum fosfat - tafla - 4 mg

Dexavit Stungulyf/innrennslislyf, lausn 4 mg/ml Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

dexavit stungulyf/innrennslislyf, lausn 4 mg/ml

vital pharma nordic aps - dexamethasonum natríumfosfat - stungulyf/innrennslislyf, lausn - 4 mg/ml

Maxitrol Augndropar, dreifa Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

maxitrol augndropar, dreifa

novartis healthcare a/s - neomycinum súlfat; polymyxinum b súlfat; dexamethasonum fosfat - augndropar, dreifa

Zofran Filmuhúðuð tafla 4 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

zofran filmuhúðuð tafla 4 mg

sandoz a/s - ondansetronum hýdróklóríð - filmuhúðuð tafla - 4 mg

Zofran Filmuhúðuð tafla 8 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

zofran filmuhúðuð tafla 8 mg

sandoz a/s - ondansetronum hýdróklóríð - filmuhúðuð tafla - 8 mg